PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

W.l. Gore & Associates Gmbh

USPTO PatentsView assignee record - 856 granted patents across 142 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Explore the portfolio See the ranking
856
Total patents granted
142
CPC technology areas
21.0
Avg claims per patent
-6%
5-year filing velocity

The verdict

W.l. holds 856 US patents across 142 technology areas, rank #527 of 50,000 tracked assignees.

#527
of 50,000 US assignees by volume
Top 1%
by Innovation Score (66.3/100)
21.0
avg claims per patent
-6%
filing velocity, last 5 yrs

Portfolio overview

W.l. Gore & Associates Gmbh has been granted 856 US utility patents between 2015 and 2025, placing W.l. Gore & Associates Gmbh at rank #527 across all assignees tracked by PlainPatent. This portfolio spans 142 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.0 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, W.l. Gore & Associates Gmbh is one of the broader-portfolio assignees in the PatentsView dataset. By volume, W.l. sits between Coretronic Corporation (858 patents, rank #523) and OPEN Invention Network Llc NC (845 patents, rank #531) - the closest US assignees by grant volume. The composite Innovation Score of 66.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 415 grants, compared with 441 in the 2015–2019 window, a -6% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. W.l. Gore & Associates Gmbh's 21.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark W.l. Gore & Associates Gmbh against peers pursuing similar technology classes.

Who files at Wl's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows W.l. holds 856 patents at rank #527, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Wl

By rank, the assignees closest to #527 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Wl's primary technology class.

W.l.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

406080100120 20152016201720182019202020212022202320242025 56
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
W.l. Gore & Associates Gmbh patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 85 9.9%
2016 91 10.6%
2017 104 12.1%
2018 75 8.8%
2019 86 10.0%
2020 69 8.1%
2021 90 10.5%
2022 69 8.1%
2023 66 7.7%
2024 65 7.6%
2025 56 6.5%

Which technologies does W.l. Gore & Associates Gmbh patent most?

Top 15 of 142 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Diversified
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#527

Across all tracked assignees

Innovation Score

66.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does W.l. Gore & Associates Gmbh hold?
W.l. Gore & Associates Gmbh holds 856 US granted patents filed between 2015 and 2025, spanning 142 technology areas.
What is W.l. Gore & Associates Gmbh's Innovation Score?
W.l. Gore & Associates Gmbh has an Innovation Score of 66.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does W.l. Gore & Associates Gmbh focus on?
W.l. Gore & Associates Gmbh's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 420 patents. The company has filed patents in 142 CPC subclasses total.
Is W.l. Gore & Associates Gmbh's patent filing rate increasing or decreasing?
W.l. Gore & Associates Gmbh's recent filing velocity is -6% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for W.l. Gore & Associates Gmbh's patents?
W.l. Gore & Associates Gmbh's patents average 21.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the W.l. Gore & Associates Gmbh patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

W.l.'s 856 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - W.l. ranks #527 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.